Hypopharyngeal Cancer
📧 Sign up to get email alerts when something new happens for Hypopharyngeal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma [Phase 3]
A Phase 3 clinical trial evaluating lymphocyte-sparing radio-immunotherapy for head and neck cancers is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer [Phase 2]
This Phase 2 clinical trial is evaluating BMX-001 as a radioprotector added to standard chemoradiation therapy for head and neck cancers and…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions
This clinical trial update describes a machine learning-based risk prediction model for head and neck cancerous lesions, with recruitment no…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
This clinical trial update describes the use of blood tests and questionnaires to study adherence to preventative swallowing exercises in pa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer [Phase 2]
A Phase 2 clinical trial is testing adding chemotherapy or chemo-immunotherapy to standard surgery for advanced head and neck cancers, inclu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin [Phase 1]
Phase 1 trial evaluating the addition of M3814 (peposertib), a DNA-PK inhibitor, to radiation therapy in patients with advanced head and nec…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/Phase 3 study evaluating atezolizumab and/or bevacizumab with or without standard chemotherap…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study [Phase 2]
This document reports a Phase 2 clinical trial called HEADLIGHT evaluating intensity-modulated proton therapy or conventional X-ray therapy …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin [Phase 3]
Phase 3 clinical trial update on radiation plus cetuximab versus radiation plus non-cisplatin chemotherapy for head and neck cancer patients…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer [Phase 1]
Phase 1 trial evaluating TMV vaccine therapy alone and with pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma; cu…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) [Phase 2]
Phase 2 clinical trial evaluating sacituzumab govitecan in combination with cetuximab for head and neck squamous cell cancers is currently r…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Study Title: Oncological and Functional Results After Total Laryngectomy and Pharyngolaryngectomy
This clinical trial update reports oncological and functional outcomes after total laryngectomy and pharyngolaryngectomy for laryngeal and h…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors [NA]
The ENHANCE study is an active, not-recruiting trial assessing exercise and nutrition interventions for head and neck cancer survivors, incl…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen [Phase 2]
Phase 2 neoadjuvant trial evaluating Adebrelimab in combination with a TP chemotherapy regimen for locally advanced hypopharyngeal cancer.
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer
This clinical trial update describes a study investigating whether voice analysis can help detect recurrence in patients with laryngeal or h…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Thermoradiotherapy for Locally Advanced Head and Neck Cancer Patients [Phase 1]
Phase 1 clinical trial evaluating thermoradiotherapy for locally advanced head and neck cancers; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment [NA]
An update on a completed clinical trial evaluating exercise training and behavioral modification to boost physical activity in patients unde…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma [Phase 2]
Phase II multicenter study evaluating neoadjuvant therapy with a PD-1 inhibitor in combination with chemotherapy for locally advanced laryng…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
A clinical trial is recruiting elderly patients with head and neck squamous cell carcinoma undergoing radiotherapy. The study covers cancers…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating celecoxib added to surgery and radiation for advanced head and neck cancer; the study was terminated with results p…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer [Phase 1]
Phase 1 study evaluating adding BAY 1895344 with radiation therapy to pembrolizumab for recurrent head and neck squamous cell carcinomas, ai…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck [Phase 1]
Phase Ib trial of buparlisib (BKM120) with cisplatin and radiotherapy in high-risk locally advanced squamous cell carcinoma of the head and …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer [Phase 1]
Phase 1 trial evaluating a WEE1 inhibitor in combination with cisplatin and radiotherapy for head and neck cancers has completed.
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal Cancer [Phase 2]
Phase 2 trial evaluating tislelizumab with induction chemotherapy for larynx preservation in resectable advanced laryngeal/hypopharyngeal ca…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin [Phase 2]
Phase 2 trial evaluating sodium thiosulfate to prevent cisplatin-induced ototoxicity in patients with head and neck squamous cell carcinoma …